Anderson Robert A. 4
4 · bioAffinity Technologies, Inc. · Filed Mar 29, 2024
Insider Transaction Report
Form 4
Anderson Robert A.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-02-26−64,848→ 0 totalExercise: $1.11Exp: 2024-04-28→ Common Stock (64,848 underlying) - Exercise/Conversion
Common Stock
2024-02-26$1.16/sh+64,848$74,899→ 121,856 total
Footnotes (1)
- [F1]This option vested in 7 equal monthly installments beginning on May 28, 2014 and the balance of such option vested on December 28, 2014.